arrow
N

Niranjan Y. Sardesai

geneos therapeutics
H指数:47
被引数:7,282

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Publisher Correction: Adjuvant personalized multivalent neoantigen DNA vaccination for MGMT unmethylated glioblastoma: a phase 1 trial

出版商更正:针对MGMT未甲基化胶质母细胞瘤的辅助个性化多价新抗原DNA疫苗接种:一项1期临床试验

2026-09-010
OAAI
Adjuvant personalized multivalent neoantigen DNA vaccination for MGMT unmethylated glioblastoma: a phase 1 trial

佐剂个性化多价新抗原DNA疫苗接种用于MGMT未甲基化胶质母细胞瘤:一项1期临床试验

2026-05-010
PRE
Personalized neoantigen vaccine and pembrolizumab in advanced hepatocellular carcinoma: a phase 1/2 trial

个性化新抗原疫苗和pembrolizumab治疗晚期肝细胞癌: 1/2期试验

2024-04-0718
OAAI
Personalized neoantigen DNA vaccine GNOS-PV02 and pembrolizumab as second-line treatment for advanced hepatocellular carcinoma
2024-03-220
PRE
Intramuscular and Intradermal Electroporation of HIV-1 PENNVAX-GP(R) DNA Vaccine and IL-12 Is Safe, Tolerable, Acceptable in Healthy Adults
2020-12-0713
OAAI
Robust antibody and cellular responses induced by DNA-only vaccination for HIV
2020-07-0925
OA
Intradermal SynCon® Ebola GP DNA Vaccine Is Temperature Stable and Safely Demonstrates Cellular and Humoral Immunogenicity Advantages in Healthy Volunteers
2019-03-1983
PREAI
In Vivo Delivery of Synthetic Human DNA-Encoded Monoclonal Antibodies Protect against Ebolavirus Infection in a Mouse Model
2018-11-0141
OAAI
Protective Efficacy and Long-Term Immunogenicity in Cynomolgus Macaques by Ebola Virus Glycoprotein Synthetic DNA Vaccines
2018-10-1032
OAAI
Control of Heterologous Simian Immunodeficiency Virus SIVsmE660 Infection by DNA and Protein Coimmunization Regimens Combined with Different Toll-Like-Receptor-4-Based Adjuvants in Macaques
2018-08-0131
OAAI
Zika-Induced Male Infertility in Mice Is Potentially Reversible and Preventable by Deoxyribonucleic Acid Immunization
2018-07-2412
OAAI
An engineered bispecific DNA-encoded IgG antibody protects against Pseudomonas aeruginosa in a pneumonia challenge model
2017-09-2150
OAAI
Safety and Immunogenicity of PENNVAX-G DNA Prime Administered by Biojector 2000 or CELLECTRA Electroporation Device With Modified Vaccinia Ankara-CMDR Boost
2017-09-0227
OAAI